The U.S. Food and Drug Administration recently announced that Epclusa is now approved to treat adult patients with chronic hepatitis C virus (HCV), both with and without cirrhosis (advanced liver disease). Read the announcement to learn more about how this decision will widen the scope of treatment options for patients with HCV.

Go to Original Post